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Abstract
Background: Spinal fusion is a common orthopaedic procedure that has been previously modeled using canine,
lapine, and rodent subjects. Despite the increasing availability of genetically modified mouse strains, murine models
have only been infrequently described.
Purpose: To present an efficient and minimally traumatic procedure for achieving spinal fusion in a mouse model
and determine the optimal rhBMP-2 dose to achieve sufficient fusion mass.
Method: MicroCT reconstructions of the unfused mouse spine and human spine were compared to design a
surgical approach. In phase 1, posterolateral lumbar spine fusion in the mouse was evaluated using 18 animals
allocated to three experimental groups. Group 1 received decortication only (n = 3), Group 2 received 10 μg
rhBMP-2 in a collagen sponge bilaterally (n = 6), and Group 3 received 10 μg rhBMP-2 + decortication (n = 9). The
surgical technique was assessed for intra-operative safety, efficacy, access and reproducibility. Spines were harvested
for analysis at 3 weeks (Groups 1, 2) and 1, 2, and 3 weeks (Group 3). In phase 2, a dose response study was carried
out in an additional 18 animals with C57BL6 mice receiving sponges containing 0, 0.5, 1, 2.5, 5 μg of rhBMP-2 per
sponge bilaterally.
Results: The operative procedure via midline access was rapid and reproducible, and fusion of the murine articular
processes was found to be analogous to the human procedure. Unlike reports from other species, decortication
alone (Group 1) yielded no new bone formation. Addition of rhBMP-2 (Groups 2 and 3) yielded a significant bone
mass that bridged the L4-L6 vertebrae. The subsequent dose response experiment revealed that 0.5 μg rhBMP-2
per sponge was sufficient to create a fusion mass.
Conclusion: We describe a new approach for mouse lumbar spine fusion that is safe, efficient, and highly
reproducible. The technique we employed is analogous to the human midline procedure and may be highly
suitable for genetically modified mouse models.
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Introduction
Spinal fusion surgery has been performed since the pio-
neering work of Hibbs [1], Albee [2] and DeQuervain in
the early 20th century. When successful the procedure
has significantly reduced the morbidity associated with
spinal deformity and, controversially, discomfort. Histor-
ically, the procedure has suffered from high rates of
non-union. It has been estimated that 5-30% of spinal
fusion procedures result in pseudarthrosis [3], the causes
of which are certainly multifactorial.
Animal surgical models have been utilized extensively
to improve surgical technique and gain insight into the
mechanisms of spinal fusion failure. Larger animals such
as canine [4-8] and ovine subjects [9,10] have tradition-
ally been employed due to their close approximation of
the size and anatomy of human patients. Rat and rabbit
studies [11-21] typically represent the lower limit with
respect to size that spine fusion procedures have been
attempted. Mouse models have rarely been studied,
likely owing to the technical difficulty associated with
surgical access and technique demanded by their small
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size. Until recently, spinal fusion attempts in mice have
been limited to percutaneous injection of BMP solution
and mesenchymal stem cells into the paraspinal muscu-
lature [22,23], thereby obviating the need to surgically
expose and manipulate the vertebral structures.
Advancements in transgenic mice have encouraged the
use of surgical models that explore the impact of genet-
ics on repair and regeneration. In 2007, Rao et al. ([24])
proposed a technique for performing posterolateral lum-
bar spinal fusion in mice, using a modified version of the
paraspinal approach described by Wiltse [25]. Fusion
was induced via autogenous bone graft from donor
mouse of same strain or rhBMP-2 delivered in a collagen
sponge. Radiographic assessment demonstrated that a
dense fusion mass was formed in 62% of fusion sites, al-
though no specific breakdown was given for the bone
graft and rhBMP-2 groups. This model also featured a
prolonged operating time of 60 min.
In this study we have utilized a surgical approach in-
volving a single midline incision through the thoracol-
umbar fascia that more closely approximates the current
human midline surgical technique. Such an approach
aimed to minimize tissue trauma as well as increase visi-
bility and access to the articular processes. One other
aim of this modified procedure was to minimize the op-
erative time and maximize the experimental reproduci-
bility between subjects and the rate of spine fusion.
Methods
Anatomical Analysis by MicroCT
The spines of 5 C57BL6 mice, aged between 8 and
10 weeks, were harvested and analyzed via microCT
using a SkyScan 1174 compact microCT scanner
(SkyScan, Kontich, Belgium). Samples were scanned in
70% ethanol at 21.3 um magnification, 0.5 mm aluminium
filter, 50 kV X-ray tube voltage and 800 μA tube electric
current. The images were reconstructed using NRecon,
version 1.5.1.5 (SkyScan). A global threshold was used
representing bone tissue. Representative three-dimensional
fractures were reconstructed with sagittal slices using
CTVol Realistic Visualisation software version 2.1.0.0
(SkyScan). The structure of the lumbar spine was docu-
mented and compared with the relevant human anatomy.
Subsequently, 5 additional mice were culled and the lum-
bar spine was dissected. The relationships of the soft tissue
to the bone were observed and documented with a view to
establishing a clear and efficient surgical access to the
lumbar vertebrae which would allow secure positioning of
a collagen sponge for the delivery of osteoblast
stimulating factors.
Surgical model
18 C57BL6 mice (male and female aged 8–10 weeks)
received posterolateral lumbar spine fusion surgery.
Surgery was performed by a two surgeons in a single
sitting with anesthetic support from an experienced ani-
mal technician. Group 1 received decortication only
(n = 3), Group 2 received 10μg rhBMP-2 in a collagen
sponge bilaterally (n = 6), and Group 3 received 10 μg
rhBMP-2 + decortication (n = 9).
Mice were anaesthetized with ketamine (35 mg/kg)/
xylazine (5 mg/kg) solution administered intraperitone-
ally. Hair overlying the operative site was shaved with an
electric razor once anaesthetized and the area prepped
with iodine. Animals were positioned prone with folded
gauze beneath the abdomen, increasing the excursion of
the lumbar spine to facilitate access to and visibility of
the surgical field. The head was covered with saline
soaked gauze to protect the ears from overheating under
operating lights. rhBMP-2 marketed under the brand
name InfuseW (Medronic Australasia) was used in this
study. Prior to surgery, the collagen sponge that was
supplied with the vial of BMP for human use was cut
into 2 mm × 7 mm sections. A solution of saline and
BMP was made allowing the accurate pipetting of 10 μg
of BMP onto each sponge intra-operatively.
With the intention of fusing the lumbar spine from
L4-L6, surface anatomy was located to determine inci-
sion point. The iliac crest is approximately level with the
L5-L6 interspace [24]. This level as well as the midline
was marked with surgical pen (Figure 1A). The proced-
ure was performed under an operating microscope or
surgical loupes at 2.5× magnification. A 15 mm incision
was made in the skin made along the midline, centered
over the line running between the iliac crests
(Figure 1B). The skin was opened and held in place with
a self-retaining retractor (Figure 1C). At this point, the
midline was identified by the spinous processes. The
iliac crest was directly visible. A second 15 mm incision,
through the dorsolumbar fascia, was made in the mid-
line, along the spinous processes. The spinous processes
and lumbar paravertebral muscles have now been
accessed. The paravertebral muscles overlying the articu-
lar processes of L4-L6 were separated from the spinous
processes in a single motion by scraping a # 10 blade
down the lateral border of the spinous process and pull-
ing the muscles laterally (Figure 1D). This motion shears
the muscle at its junction to the bone minimizing
trauma to the tissue. This was performed bilaterally ex-
posing the articular processes and creating a potential
space between muscle and bone. Muscle was retracted
bilaterally with a purpose-built micro-retractor allowing
controlled and gentle retraction while maintaining max-
imum visibility of all articular processes. A pneumatic 1
mm round tip diamond burr was used to decorticate the
visible articular processes until punctuate bleeding was
observed. Care was taken not to disturb surrounding
muscle tissue.
Bobyn et al. Journal of Orthopaedic Surgery and Research 2013, 8:2 Page 2 of 9
http://www.josr-online.com/content/8/1/2
Two collagen sponges, impregnated with either saline
or an rhBMP-2/saline solution (containing 10 μg of
BMP per sponge), were placed bilaterally in the potential
space which has been created (Figure 1E). The fascia
was apposed and closed with a single line of continuous
sutures using 6.0 Vicryl, The skin was subsequently
closed in the same fashion. Mice were placed on a heat
pad following surgery and monitored for recovery. Anti-
biotics were administered in the drinking water for 24
hours postoperatively.
Study design
Once the safety and efficacy of the surgical model had
been demonstrated, it was applied to a small study in-
volving 15 C57BL6 mice to determine the optimal dose
of rhBMP-2 required to establish fusion of the spine.
Mice were divided into dose groups of 0, 0.5, 1, 2.5, and
5 μg of rhBMP-2 per sponge bilaterally and culled at 3
weeks. Spines were harvested and fixed in 4% parafor-
maldehyde for 24 hours and then analyzed by X-ray and
microCT were used to visualize new bone formation.
Figure 1 Following the administration of anesthetic the mouse was positioned prone. A marker was used to mark the location of the
spinous processes, vertical line, and pelvic crest, horizontal line (A). A line drawn across the pelvic crests corresponds to the position of the L5-L6
interspace. (B). An incision was made through the skin which was the held by a self-retaining retractor. (C) A single incision was made through
the thoracolumbar fascia over the spinous processes and the paravertebral musculature was dissected by scraping a blade down along the
spinous processes and pulling laterally. The dissection of the local musculature forms a pocket on either side of the spine, bounded medially by
the spinous processes and inferiorly by the articular processes (D). The articular processes are consequently exposed and visualized using a small
muscle retractor of our own design. Articular processes are subsequently decorticated with a 1 mm round diamond burr until punctate bleeding
is observed. Following decortication of the visualized articular processes, a 7 mm × 2 mm collagen sponge impregnated with either saline or
saline/rhBMP-2 solution is inserted into each of the pockets in contact with the posterior elements of the spine (E). The muscle and skin are then
closed with continuous sutures using 5.0 VicrylW.
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Radiography
Following harvesting and fixation in 4% paraformalde-
hyde, microCT data was obtained via SkyScan 1174
compact microCT scanner (SkyScan, Kontich, Belgium).
Samples were scanned in 70% ethanol at 21.3 um magni-
fication, 0.5 mm aluminum filter, 50 kV X-ray tube volt-
age and 800 μA tube electric current. The images were
reconstructed using NRecon, version 1.5.1.5 (SkyScan).
A global threshold was used representing bone tissue.
Representative three-dimensional fractures were recon-
structed with sagittal slices using CTVol Realistic
Visualization software version 2.1.0.0 (SkyScan). For the
purposes of bone volume and density calculation, the
bone of the fusion mass was isolated from native bone
by means of manually drawn regions of interest (ROI).
Histology
Harvested vertebrae and surrounding musculature were
fixed in 4% paraformaldehyde for 24 hours at 4°C on a
shaker were and then stored in 70% ethanol until ready
for decalcification. Samples were decalcified in 0.34M
EDTA (pH 8.0) solution at 4°C on a shaker for 30 days
with solution changes every 2–3 days. Samples were
next embedded in paraffin and sectioned transversely
through the center of the fusion mass at a thickness of 5
microns. Mounted sections were stained via Picro Sirius
Red/Alcian Blue to differentiate bone and cartilage.
Statistics
The significance of the medians and distribution of bone
volume data as a function of increasing dose was
first analyzed via stringent non-parametric statistics
(Kruskal-Wallis independent sample test; SPSS Statistics
v18). Using an assumption of normally distributed data,
an ANOVA with post-hoc Bonferroni test was then per-
formed to compare individual groups. The limit for stat-
istical significance was set at 0.05. Correlation was tested
using a Pearson product–moment correlation test (Excel
2010) to generate the R-value. Significance was tested by
calculating the t-value using the formula t = (r*(n-2)
^0.5)/((1-r^2)^0.5) and significance calculated using the
tdist function.
Ethics
All animal experimentation was performed with ethics
approval granted by the Westmead Hospital Animal
Ethics Committee under protocol 5056.
Results
Anatomical examination of the unfused mouse spine
MicroCT images of the mouse lumbar spine were
compared to human anatomical scans (Figure 2). Com-
parison of both species showed shared similar vertebral
structures, although their position and orientation
differed between species. Of particular note was the
positioning of the transverse process (TP) in the mouse
lumbar vertebrae. In the human, the TP is located pos-
terolaterally, and is therefore the anchor point in poster-
olateral spine fusion. In contrast, in the mouse it is the
inferior articular processes, rather than the transverse
processes that share this orientation. For the purposes of
modeling a human surgery in a mouse, we concluded
that a posterolateral interarticular process spine fusion
would more closely approximate the posterolateral inter-
transverse procedure used in humans today.
Surgical timing and morbidity
There was no intra- or post- operative morbidity or
mortality in either the fusion outcome study or the
rhBMP-2 dose response study. Animals were monitored
for neurological impairment (particularly of the hind
limbs), wound infection, weight loss and distressed
behavior. Operative time, in the hands of an experienced
surgeon, was approximately 15 minutes skin to skin. We
believe that the brief operating, and hence anesthetic
time as well as the minimized trauma contributed sig-
nificantly to the observed safety of the procedure.
Fusion outcomes
Our results were consistent with previous studies [24],
demonstrating little or no bone growth evident in
decortication-only control animals on micro-CT recon-
struction as well as in decortication/BMP animals culled
at 1 week. By week 2, a significant volume of bone was
observed in all animals which received BMP-2. The bone
bridge typically united all vertebrae from L2/3-L6 with
an AP dimension equal to or greater than that of the
lumbar vertebrae to which it has fused (Figure 3). The
bone mass was homogenously of lower density that the
vertebral cortical bone. At week 3, areas of centralized
resorption were noted in the bone mass. Decortication
does not appear to have contributed significantly to new
bone formation. MicroCT reconstructions were sup-
ported by histology (Figure 4). Paraffin sections stained
with Picro Sirius Red/Alcian Blue stain demonstrated an
abundance of collagen, stained blue, overlying the pos-
terior elements of the spine. The observed collagen is
likely a remnant of the collagen sponge used to deliver
the rhBMP-2 and was associated with lateral displace-
ment of the perispinal musculature, stained green. No
new bone formation, stained red, was observed at 1
week time points in any group. Overwhelming bone for-
mation was observed at the 2 week end point in all
groups dosed with rhBMP-2. The size of the fusion mass
was unchanged at 3 weeks. However, consistent with
microCT data, an area of centralized resorption was evi-
dent. This was visualized as a reduction of red staining
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Figure 2 Three-dimensional reconstructions of CT images demonstrating the anatomy of murine lumbar spine (left) vs human lumbar
spine (right). (A) Anterior vertebral body. (B) Transverse process. (C) Inferior articular process. The position and orientation of the transverse
process of the mouse spine differs significantly from the human spine. Both the murine inferior articular process and the human transverse
process share a lateral orientation.
Figure 3 Volume of the BMP induced fusion mass was assessed via microCT using a Skyscan 1174 scanner. A fusion mass was only
produced in groups in which BMP was implanted. No new bone was observed at 1 week post op, while maximum fusion volume
was achieved by week 2 and maintained at week 3. Decortication of the articular processes alone was insufficient to achieve new
bone formation. A reconstructed sagittal view of a fused spine at 3 weeks is shown at the lower right. The section is taken from the
midline, a dense fusion mass uniting the vertebrae of L1-L5.
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structures in the center of the fusion mass relative to
samples obtained at 2 weeks.
rhBMP-2 dose response study
A dose responsive relationship was observed between
the rhBMP-2 dose and size of the fusion mass (Figure 5).
When collagen sponges were added with 0μg of rhBMP-
2, no fusion mass was observed. MicroCT data showed
that a dose as low as 0.5 μg was able to promote fusion
and the amount of bone formed increased with increas-
ing rhBMP-2 dose (Figure 6). The significance of the
distribution of bone volume data as a function of in-
creasing rhBMP-2 dose was found to be different by
non-parametric independent sample analysis (P < 0.01)
and also by ANOVA (P < 0.01). Post-hoc intergroup test-
ing showed significant differences between the induced
Figure 4 Histological samples retrieved from fused murine vertebrae. Samples have been stained with Pico Sirius red and Alcian blue
stain to differentiate between bone and collagen. At 1 week, a large collagen mass overlaying the posterior elements of the vertebrae
forms with disruption of local musculature. By the second week postoperatively, a large bony mass that was continuous with the
cortex of the vertebrae was present. This mass exhibited a resorptive marrow-like center by week 3. No new collagen or bone was
observed in the decortications only spine.
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bone volumes between the 0 μg (no treatment) group
and the 2.5 μg, 5 μg, and 10 μg rhBMP-2 groups (all P <
0.01). Bonferroni post-hoc intergroup testing showed sig-
nificant differences between the induced bone volumes
between the 10 μg groups and the 0 μg (0.000), 0.5 μg
(0.005) and 1 μg (0.051) groups as well as between the
0 μg and the 2.5 μg (0.008) and 5 μg (0.005) groups.
Based on the increasing dose responsiveness, the correl-
ation between rhBMP-2 and bone volume formed was
tested using a Pearson correlation test and confirmed a
strong linear relationship (R = 0.74, P < 0.01).
Discussion
Historically, larger animals have been used to model
spine fusion surgery due to their proximity in size and
anatomy to humans. Recent advancements in transgenic
mice have generated an experimental niche for the use
of murine surgical models. Knockout and transgenic
mice offer a unique opportunity for insight into the gen-
etic and cellular mechanisms underlying bone repair
[26]. Idiopathic scoliosis (IS) is the most common cause
of spinal deformity in children, but the etiology of the
disease has remained elusive. Recent research has found
a strong association between mutations of the CHD7
gene and the development of IS [27]. The potential
exists to replicate CHD7-mutation dependent IS in
transgenic mice and to investigate intervention therapies
in an accurate murine model. Similar advantages are
offered to the modeling of scoliosis in neurofibromatosis
type 1 (NF1) patients. NF1 is the most common single
gene disorder and at least 23% of patients diagnosed
with NF1 will show signs of scoliosis in childhood
[28,29]. A mouse model for modeling human NF1 defi-
ciency is currently available, and while it does not spon-
taneously develop scoliosis it shows impaired long bone
healing and response to rhBMP treatment [30,31]. There
are several additional advantages using the mouse as an
experimental organism. The small size of the mouse,
though technically challenging, facilitates relatively quick
operations and allows for low intra-operative morbidity
and mortality. Furthermore, when combined with its
short generation time and inexpensive housing costs,
makes it a valuable high throughput model.
A major drawback to using the mouse to replicate
human surgery lies in the anatomical differences be-
tween the two species. With respect to the lumbar spine,
Figure 5 AP and lateral microCT images demonstrating the volume of new bone formed in response to rhBMP-2 dose. To the right of
each set of microCT images was a cross sectional image of the spine taken at its widest point in the transverse plane. An increase in
the size of the fusion mass was observed with increasing rhBMP-2 dose. It was noted that at a dose of 0.5 μg sufficient bone was
formed to bridge the L4-L6 vertebrae resulting in successful fusion.
Figure 6 Volume of spine fusion bone mass as a function of
rhBMP-2 dose. A dose–response relationship was observed with
consistent bone mass being formed with a dose as low as 0.5
μg of rhBMP-2. Bone volume data for the 10 μg dose (n = 6)
is included from the first phase and was consistent with the
dose–response trend.
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our investigation into the murine anatomy yielded sev-
eral distinct morphological differences between the
mouse and the human lumbar vertebrae which have
been previously overlooked, particularly the position and
orientation of the transverse processes. However, the
structural similarities of the mouse articular processes
and the human transverse processes may be exploited to
yield a procedure that is functionally analogous to that
which is performed in humans.
Previous mouse and rat models of posterolateral spine
fusion have adopted a modification of the Wiltse technique
which utilizes a paraspinal approach to the transverse pro-
cesses [19,24,25]. Given the anatomical differences between
rodents and humans we don’t believe that this is an optimal
approach. Furthermore, the Wiltse technique uses twice as
many incisions as a midline approach and is not currently
in popular practice. The result is a procedure that does not
mimic contemporary technique or relevant anatomy and
leads to longer operating times with a consequent risk of
increased morbidity and mortality. The surgical approach
used in this study minimizes the number of incisions, tissue
trauma and ultimately the total operative time. In mice
who only received articular process decortication as inter-
vention, no bone formation was observed. Additionally,
little difference was observed by the addition of decortica-
tion to the mice receiving rhBMP-2 suggesting intrinsic
intraspecies differences with larger animals. Canines have
been reported to readily fuse following decortication alone
[32], and decortication is also a common clinical practice in
spine fusion surgery.
Our initial study used an rhBMP-2 dose of 10μg per
sponge, based upon scaling down doses commonly used
to create a large bone mass in rabbits [33,34]. This
yielded a very large amount of bone formation which is
equal to or greater in volume than the spine itself. Such
a large mass of bone suggests that the mouse spine is
particularly sensitive to the osteogenic effects of rhBMP-
2 and that a functional and stabilizing fusion mass could
be achieved with a lower dose. We propose that the
overwhelming response to the 10 μg dose may be ob-
scuring the influence of additional variables, such as dec-
ortications of the articular processes. A follow-up study
was performed to determine the minimum dose of
BMP-2 required for fusion. A dose response relationship
between rhBMP-2 and the volume of the 3 week fusion
mass was observed. It was found that a dose of 0.5 μg,
equivalent to 5% of the original dose, was sufficient to
achieve successful fusion. The resulting fusion mass was
significantly smaller than that achieved using 5 μg or 10
μg rhBMP-2. This smaller fusion mass may be more sen-
sitive to the effects of intervention.
In summary, we have demonstrated that a midline ap-
proach to posterolateral interarticular process spine fu-
sion in a mouse model is safe, efficient, and yields
consistent and reproducible results. A BMP-2 dose of
0.5 μg per sponge was sufficient to achieve fusion of ad-
jacent vertebrae. By exploiting anatomical similarities be-
tween the species, the technique closely mirrors that
which is used in humans. The development of a surgical
protocol in mice that is functionally analogous to the
procedure in human patients is advantageous. This
model permits the rapid observation of a large number
of subjects over a relatively short period of time and
allows valid extrapolation of reproducible data and
results, thereby fulfilling the criteria for the ideal animal
model as proposed by Schimandle and Boden [20].
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